Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AACR, Academy, affiliated, aggressive, aimed, alleviate, assumption, augment, Baker, behavior, biology, blast, blinded, bystander, carboplatin, Celgene, cGMP, circumstance, Clolar, Cloretazine, Composite, composition, cooperation, coordinated, curve, customary, daunorubicin, derecognized, developmental, diffuse, DLBCL, double, Eli, etoposide, exceeding, Felix, fewer, follicular, Genzyme, Graph, guide, GVD, ICE, ifosfamide, immunomodulatory, improper, induction, ineligible, insignificant, intensify, irrespective, Laureate, led, Lilly, lintuzumab, lymphoproliferative, mantle, marginal, methodology, MMAE, NHL, nonrefundable, older, overestimate, pediatric, Pharma, placebo, pool, Progenic, prolong, protocol, qualitative, quantifying, quantitative, rebalance, recurrent, reinvestment, speed, sublicensed, sublicensee, threshold, transfusion, transition, Treasury, uncorrected, unrecognized, vasculature, Vectibix, Vion, weighted, windfall, zone
Removed:
ADEPT, administered, allocate, assigned, billing, Celltech, chimeric, conditional, conjugated, Contingently, creating, customer, divided, downstream, embedded, ending, enterprise, enzyme, exposure, fight, Food, front, geographic, growing, highest, hydrazone, immunologic, implemented, inactivate, inactive, induced, inflammatory, interim, interpreted, investigating, kilogram, leaving, lung, minimal, mixture, mouse, NSCLC, obligate, potentially, prodrug, reached, release, Reseller, sequencing, shared, structure, Taxotere, toxin, Vendor, vialed
Filing tables
Filing exhibits
- 10-K Annual report
- 10.47 Executive Employment Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer
- 32.2 Certification of Chief Financial Officer
Related press release
SGEN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-111269 and No. 120703) and Form S-8 (No. 333-56670) of Seattle Genetics, Inc. of our report dated March 8, 2007, relating to the financial statements, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appear in this Form 10-K.
/s/ PricewaterhouseCoopers LLP |
PricewaterhouseCoopers LLP |
Seattle, Washington |
March 8, 2007 |